治疗急性失补偿的膜心脏病的管理
Enzo Lüsebrink1, Hugo Lanz1, Antonia Kellnar1
1Department of Medicine I, LMU University Hospital, LMU Munich, Munich, Germany and DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.
European journal of heart failure
|December 12, 2024
概括
膜心脏病 (VHD) 经常导致急性心力衰竭. 本综述侧重于VHD相关急性心力衰竭的透导管疗法,提供管理算法,以改善患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏衰竭管理的管理
背景情况:
- 急性心力衰竭通常是由膜心脏病 (VHD) 引起的,导致快速的血液动力学变化和心脏功能障碍.
- 目前的指导方针缺乏针对VHD引起的急性心力衰竭管理的具体建议.
- 未经治疗的VHD引起的急性心力衰竭可能会进展到脱补偿和心脏性休克.
研究的目的:
- 审查由VHD引起的急性心力衰竭的管理,强调通过导管治疗.
- 综合有关门病理的证据,包括大动脉狭窄,大动脉吐, mitrale 吐和 mitrale 狭窄.
- 开发治疗算法,以优化与VHD相关的急性心力衰竭管理.
主要方法:
- 系统的文献搜索关于急性心力衰竭或心脏性休克的紧急/紧急门干预的文章.
- 选了2234篇文章,其中包括1994年至2023年间发表的76篇.
- 专注于对大动脉狭窄,大动脉吐, mitra 吐和 mitra 狭窄的结果.
主要成果:
- 有证据表明,通过导管治疗对于VHD患者的急性心力衰竭越来越重要.
- 通过透气管干预的结果有所改善,特别是在高风险的手术患者中.
- 基于合成的证据创建了治疗算法.
结论:
- 过导管疗法对于治疗VHD急性心力衰竭至关重要,特别是在高风险患者中.
- 最少侵入性的选择可能会在急性VHD管理中发挥更大的作用.
- 本综述为复杂的VHD相关急性心力衰竭治疗提供了一种有组织的方法.
相关概念视频
01:25Mitral Regurgitation III: Medical Management
4
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
4
01:28Mitral Regurgitation IV: Nursing Management
2
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
2
01:19Mitral Valve Prolapse III: Nursing Management
4
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
4
01:22Mitral Valve Prolapse II: Assessment and Management
2
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
2
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
385
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
385